Associated Press/AP Online
By MARILYNN MARCHIONE
BOSTON - A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor's office.
Boston scientists who invented the test and health care giant Johnson & Johnson will announce Monday that they are joining forces to bring it to market. Four big cancer centers also will start studies using the experimental test this year.
Stray cancer cells in the blood mean that a tumor has spread or is likely to, many doctors believe. A test that can capture such cells has the potential to transform care for many types of cancer, especially breast, prostate, colon and lung.
Initially, doctors want to use the test to try to predict what treatments would be best for each patient's tumor and find out quickly if they are working.
That's funny, I had that test done three years ago.
Hey, maybe next year we're going to invent a chemotherapy sensitivity test... Oh, wait a minute, I had that done three years ago too.
PS. I'm doing great. Scans are clear and I've gained 7 pounds... in a year.